Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
Innovators in Therapeutics Speaker Series
Dr. David Altshuler, Executive VP, Global Research, CSO, Vertex Pharmaceuticals
March 24, 2023 12 – 12:45pm ET
RegSci Forum “Dubious FDA approvals”
Dr. Vinay Prasad | April 4, 2023 12 – 1pm ET